BioSpace News Archive

Biotech Beach

Study: Men More Likely to Experience Damaging Antibodies after COVID-19 Illness

While women are more statistically susceptible to autoimmune diseases, the research found that men with at least a mild COVID-19 infection had far more autoantibody (AAB) reactivity.

January 4, 2022
·
2 min read
·
Kate Goodwin
BioMidwest

Money on the Move: December 29 – January 4

Here’s who rang in the New Year by joining the NASDAQ or raising private equity funds.

January 4, 2022
·
2 min read
·
Kate Goodwin
Business

Top Life Sciences Startups to Watch in 2022

BioSpace is proud to present its NextGen Bio “Class of 2022,” a list of up-and-coming life sciences companies in North America that recently launched.

January 4, 2022
·
19 min read
·
Heather McKenzie
Business

French Biotech Raises $200 Million Series C for DNA Printing Platform

DNA Script announced it secured a $200 million Series C financing, bringing the total amount raised by the biotech company to $315 million since its founding in 2014.

January 4, 2022
·
2 min read
·
Alvin Clavines
Beyond the Business Pitch - Plan, Build Relationships and Deliver Succinctly

This year’s virtual J.P. Morgan Week is spurring companies to expand meeting slots throughout the month and conduct more relaxed, productive encounters.

January 4, 2022
·
4 min read
·
Gail Dutton
Business

Biogen Scoops Up Another SMA Drug from Ionis

Biogen exercised an option to pick up an exclusive global license for a drug to treat spinal muscular atrophy from Ionis. The compound, BIIB115, is an antisense oligonucleotide.

January 4, 2022
·
2 min read
·
Mark Terry
Policy

Holmes Could Face Decades in Prison Following Guilty Verdict on Four Counts

Elizabeth Holmes, the founder and former CEO of Theranos, has been found guilty of bilking hundreds of millions of dollars from investors to prop up her company.

January 4, 2022
·
3 min read
·
Alex Keown
Business

Drug Price Increases for 460 Drugs in 2022

Companies large and small have increased the prices of their drugs so far this week. The drug price increases when the market is seeing high inflation.

January 4, 2022
·
2 min read
·
Alex Keown
Policy

Fourth Scientist Pleads Guilty to Stealing GSK Information for China

The indictment against the scientists point in specific to GSK’s code of conduct, which prohibits any company information from being shared externally without approval.

January 4, 2022
·
2 min read
·
Vanessa Doctor, RN
Drug Development

FDA Lifts 11-Month Hold on Spero’s Lung Disease Drug

The FDA decided to lift the hold for its Phase IIa trial of SPR720 after Spero submitted a comprehensive analysis from the NHP toxicology study.

January 4, 2022
·
3 min read
·
Mark Terry